Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,627 signal articles · 46 in last 24h · 155,673 total before filter · latest 1h ago
46last 24h
846last 7d
141● bullish (7d)
89● bearish (7d)
214publishers
AllMacro196Earnings105M&A122Regulatory20Product21Analyst19
✕ clear all filtersticker: ^GSPCSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
3 Software Stocks We Keep Off Our Radar
StockStory40d agoneutral
3 Software Stocks We Keep Off Our Radar

From commerce to culture, software is digitizing every aspect of our lives. This secular theme has materialized in superior earnings growth and stock price performance for most SaaS companies, and over the last six months, the industry’s 45.2% return has topped the S&P 500 by 31.3 percentage points.

3 Reasons to Sell BKU and 1 Stock to Buy Instead
StockStory40d agoneutral
3 Reasons to Sell BKU and 1 Stock to Buy Instead

BankUnited currently trades at $48.27 per share and has shown little upside over the past six months, posting a small loss of 1.8%. The stock also fell short of the S&P 500’s 13.9% gain during that period.

'Fear Gauge' Falls To Year's Low. A Bad Sign For The Stock Market?
Investor's Business Daily40d agobearish
'Fear Gauge' Falls To Year's Low. A Bad Sign For The Stock Market?

The stock market's so-called fear gauge fell Friday to the lowest level of the year, showing remarkable optimism among investors despite worries of higher interest rates and an unclear path for the Iran conflict. The Cboe Market Volatility index, better known as the VIX, fell to 14.18 at Friday's low and closed at 14.25. For comparison, the VIX jumped as high as 31.65 on March 27, the highest reading so far this year.

3 Reasons to Sell CLAR and 1 Stock to Buy Instead
StockStory40d agoneutral
3 Reasons to Sell CLAR and 1 Stock to Buy Instead

Clarus has followed the market’s trajectory closely, rising in tandem with the S&P 500 over the past six months. The stock has climbed by 12.3% to $3.65 per share while the index has gained 13.9%.

3 Reasons MTN is Risky and 1 Stock to Buy Instead
StockStory40d agobullish
3 Reasons MTN is Risky and 1 Stock to Buy Instead

Although Vail Resorts (currently trading at $148.25 per share) has gained 7.6% over the last six months, it has trailed the S&P 500’s 13.9% return during that period. This might have investors contemplating their next move.

RBC's Lori Calvasina Sees S&P 500 Upside Despite Fed Risk
Bloomberg40d agoneutralVIDEO
RBC's Lori Calvasina Sees S&P 500 Upside Despite Fed Risk

Wall Street traders sent stocks and bonds wavering in the Monday session as fresh Middle East violence stoked concerns about an escalation of the war that has jolted global markets. Following the S&P 500's longest weekly advance since May, the gauge fluctuated. Chipmakers rallied as Anthropic PBC's revenue surge bolstered bets on the artificial-intelligence trade. Brent crude rose to around $89, leaving traders wary about inflationary pressures that could make the Federal Reserve raise rates. Treasury 30-year yields hit the highest since 2007. Lori Calvasina, Head of US Equity Strategy at RBC Capital Markets, explains why Fed policy uncertainty, potential rate hikes and valuation concerns may not be enough to derail the equity rally. She speaks to hosts Tom Keene and Paul Sweeney on Surveillance Radio.

3 Reasons to Avoid CPNG and 1 Stock to Buy Instead
StockStory40d agobullish
3 Reasons to Avoid CPNG and 1 Stock to Buy Instead

Over the past six months, Coupang’s shares (currently trading at $16.13) have posted a disappointing 7.4% loss, well below the S&P 500’s 13.9% gain. This may have investors wondering how to approach the situation.

3 Reasons DIN is Risky and 1 Stock to Buy Instead
StockStory40d agobullish
3 Reasons DIN is Risky and 1 Stock to Buy Instead

Although Dine Brands (currently trading at $35.15 per share) has gained 6.6% over the last six months, it has trailed the S&P 500’s 13.9% return during that period. This might have investors contemplating their next move.

ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?
StockStory40d agoneutral
ICU Medical (ICUI): Buy, Sell, or Hold Post Q2 Earnings?

ICU Medical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 9.3%. The stock now trades at $182.79, marking a 23.3% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Tronox Holdings Plc (TROX) Pressured by Softer Guidance and Leverage Risks
Insider Monkey40d agoneutral
Tronox Holdings Plc (TROX) Pressured by Softer Guidance and Leverage Risks

Voya Investment Management, an investment management company, released its second-quarter 2026 investor letter for its “Voya MI Dynamic Small Cap Fund.” A copy of the letter can be downloaded here. US Equity markets rebounded strongly in the second quarter of 2026, recovering from geopolitical tensions that nearly pushed the S&P 500 Index into correction territory. […]

Flowserve Corporation (FLS) Trims Full-Year Growth Outlook as Organic Sales Decline ~1%
Insider Monkey40d agoneutral
Flowserve Corporation (FLS) Trims Full-Year Growth Outlook as Organic Sales Decline ~1%

Voya Investment Management, an investment management company, released its second-quarter 2026 investor letter for its “Voya MI Dynamic Small Cap Fund.” A copy of the letter can be downloaded here. US Equity markets rebounded strongly in the second quarter of 2026, recovering from geopolitical tensions that nearly pushed the S&P 500 Index into correction territory. […]